Docket Room.
HCR 134·HI·house

URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.

FailedFiled Mar 16, 2026
Sponsor: ALCOS
Latest Action

Referred to HLT, CPC, referral sheet 19

Mar 18, 2026

Email me when HCR 134 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HCR 134. By continuing you agree to the Terms and Privacy Policy.

Summary

The concurrent resolution asks the Hawaii State Director of Health to issue a statewide order permitting people to buy nebulized budesonide without a prescription or doctor’s consultation. It also encourages the Board of Pharmacy to set labeling and instruction rules for the product and its nebulizer devices. The measure aims to expand access to a medication the sponsors say can help treat respiratory illnesses like COVID‑19.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HCR 134

3 free questions a day, no account

History

  1. Referred to HLT, CPC, referral sheet 19
  2. Offered

Sponsors

  • ALCOS · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HCR 134 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HCR 134 free

Or ask your AI assistant about HCR 134 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice